SCHEMBL14333772

SCHEMBL14333772

O=S(=O)(NCc1ccnc2ccccc12)c1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 4/20 0.53
▸ LMNA P02545 4/20 0.53
▸ KEAP1 Q14145 1/20 0.51
▸ HTT P42858 3/20 0.48
▸ ALDH1A1 P00352 3/20 0.48
▸ LOXL2 Q9Y4K0 1/20 0.47
▸ MCL1 Q07820 1/20 0.44
▸ CA12 O43570 1/20 0.44
▸ CA1 P00915 1/20 0.44
▸ CA2 P00918 1/20 0.44
▸ CA9 Q16790 1/20 0.44
▸ NPY1R P25929 1/20 0.44
▸ NPY5R Q15761 1/20 0.44
▸ ADAMTS4 O75173 1/20 0.44
▸ MMP13 P45452 1/20 0.44
▸ KDM4E B2RXH2 1/20 0.44
▸ PKM P14618 1/20 0.44
▸ PRMT1 Q99873 1/20 0.43
▸ CYP1A2 P05177 1/20 0.43
▸ MAPT P10636 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14334349 0.89 KEAP1 (0.48) SMN1; SMN2LMNAKEAP1HTTALDH1A1
SCHEMBL14992892 0.89 SMN1; SMN2 (0.47) SMN1; SMN2LMNAHTTALDH1A1LOXL2
SCHEMBL4508326 0.89 CYP19A1 (0.50) SMN1; SMN2HTTALDH1A1LOXL2NPY1R
SCHEMBL15819472 0.88 HTT (0.50) SMN1; SMN2LMNAHTTALDH1A1CA12
SCHEMBL15643222 0.85 ADAMTS4 (0.51) SMN1; SMN2ALDH1A1MCL1ADAMTS4MMP13
SCHEMBL15841261 0.84 HTT (0.48) SMN1; SMN2LMNAHTTALDH1A1LOXL2
SCHEMBL14334121 0.83 CYP19A1 (0.48) SMN1; SMN2LMNAKEAP1HTTALDH1A1
SCHEMBL15643545 0.82 CYP19A1 (0.44) SMN1; SMN2LMNAHTTALDH1A1NPY1R
SCHEMBL14992486 0.81 PRMT1 (0.43) SMN1; SMN2HTTALDH1A1NPY1RNPY5R
SCHEMBL14993097 0.80 ADAMTS4 (0.45) SMN1; SMN2LMNAHTTALDH1A1NPY1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2721006-A1 HETEROCYCLIC COMPOUNDS FOR TREATING HELMINTH INFECTIONS E. I. Du Pont de Nemours and Company (US) 2014-04-23 — — EP claimed
WO-2012177668-A1 HETEROCYCLIC COMPOUNDS FOR TREATING HELMINTH INFECTIONS E. I. DU PONT DE NEMOURS AND COMPANY (US) 2012-12-27 — — WO claimed
EP-2721006-A1 HETEROCYCLIC COMPOUNDS FOR TREATING HELMINTH INFECTIONS E. I. Du Pont de Nemours and Company (US) 2014-04-23 — — EP disclosed
WO-2012177668-A1 HETEROCYCLIC COMPOUNDS FOR TREATING HELMINTH INFECTIONS E. I. DU PONT DE NEMOURS AND COMPANY (US) 2012-12-27 — — WO disclosed
Send feedback